CAVA Crowd Favorites, Made Diabetes-Smart: What to Order
If CAVA is one of your favorite spots to dine in, here’s our little guide to help you amp up the flavor while being…
Do you have Type 2 Diabetes and use (or are willing to start) basal insulin? You may qualify for a research study evaluating a new glucose monitoring system.
This study is designed to evaluate how an FDA-cleared CGM system and basal insulin dose calculator work, and to confirm it is safe to use. Participants will wear the study CGM device and use a mobile app that provides daily insulin dose recommendations for approximately 4 months. Weekly telephone check-ins are also included.
To take part in the study, participants should:
CEO and Medical Director
Director of Clinical Research
Clinical Research Coordinator
Navigator/Study Start-up Manager
Clinical Research Coordinator
Clinical Research Coordinator